IndraLab

Statements


UCHL1 decreases the amount of APP. 9 / 12
| 9

reach
"Inhibition of UCHL1 activity significantly increased BACE1 protein expression and increased concentrations of amyloid β, whereas overexpression of UCHL1 decreased amyloid β levels and delayed AD progression (Zhang et al., 2014; Zhang et al., 2012)."

reach
"Inhibition of UCHL1 by the compound LDN57444 has been shown to elevate APP levels ."

reach
"Mature APP level was reduced by UCHL1 as expected (p < 0.05) (XREF_FIG), and was further reduced by ubiquitin expression (p < 0.01) (XREF_FIG)."

reach
"Overexpression of either UCHL1 or ubiquitin depleted APP levels while increasing its ubiquitination (Fig. 3f; Supplementary Fig. 4j)."

reach
"This study suggests that potentiation of UCHL1 might be able to reduce the level of BACE1 and Abeta in brain, which makes it a novel target for AD drug development."

reach
"Overexpressing Uch-L1 reduces BACE1 activity and Abeta levels, whereas Uch-L1 null mice exhibit increased number of Abeta plaques and neurofibrillary tangles, thus displaying an inverse relationship with Uch-L1 levels."

reach
"Inhibition of UCHL1 activity significantly increased concentrations of amyloid β, whereas overexpression of UCHL1 decreased amyloid β levels and delayed AD progression [51]."

reach
"Concordant with this fact, a research using different cellular models such as neuroblastoma SH-SY5Y and NT (2) neuronal cells shows that Abeta42 treatment downregulates UCHL-1 and this down-regulation is dependent on NF-kappaB activation and on impaired BACE1 lysosomal degradation.39 Ubiquitin C-terminal hydrolase-1 accelerates BACE1 degradation and affects APP processing and Abeta production.40 In conclusion, potentiation of UCHL-1 might be able to reduce the levels of BACE1 and Abeta in brain, and UCHL-1 may be a novel target for AD drug development."

reach
"To investigate whether UCHL1 reduced APP protein level by the lysosomal degradation, Haw cells were transfected with UCHL1 and then treated with 100muM chloroquine (XREF_FIG)."